DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Zydus Wellness Limited — Change in Management

NSE 1 hr ago·1 Sept 2026, 4:15 am

Zydus Wellness

Zydus Wellness has announced the appointment of Mr. Kapil Sharma as Chief Revenue Officer, a key role within the company's senior management team. This move signals a strategic reinforcement of the leadership to drive growth in its consumer health and nutrition business segments.

For investors, this development is generally viewed positively as it brings in specialized expertise to manage revenue streams. It suggests the company is actively strengthening its management structure to navigate a competitive market and execute its business plans effectively.

Investors should monitor the company's future quarterly results to see if Sharma's appointment leads to improved sales performance and market share gains. Keeping an eye on management commentary regarding future growth strategies will also be important.